Literature DB >> 24844846

Kidney function and cognitive health in older adults: the Cardiovascular Health Study.

Brendan Darsie, Michael G Shlipak, Mark J Sarnak, Ronit Katz, Annette L Fitzpatrick, Michelle C Odden.   

Abstract

Recent evidence has demonstrated the importance of kidney function in healthy aging. We examined the association between kidney function and change in cognitive function in 3,907 participants in the Cardiovascular Health Study who were recruited from 4 US communities and studied from 1992 to 1999. Kidney function was measured by cystatin C-based estimated glomerular filtration rate (eGFRcys). Cognitive function was assessed using the Modified Mini-Mental State Examination and the Digit Symbol Substitution Test, which were administered up to 7 times during annual visits. There was an association between eGFRcys and change in cognitive function after adjustment for confounders; persons with an eGFRcys of less than 60 mL/minute/1.73 m(2) had a 0.64 (95% confidence interval: 0.51, 0.77) points/year faster decline in Modified Mini-Mental State Examination score and a 0.42 (95% confidence interval: 0.28, 0.56) points/year faster decline in Digit Symbol Substitution Test score compared with persons with an eGFRcys of 90 or more mL/minute/1.73 m(2). Additional adjustment for intermediate cardiovascular events modestly affected these associations. Participants with an eGFRcys of less than 60 mL/minute/1.73 m(2) had fewer cognitive impairment-free life-years on average compared with those with eGFRcys of 90 or more mL/minute/1.73 m(2), independent of confounders and mediating cardiovascular events (mean difference = -0.44, 95% confidence interval: -0.62, -0.26). Older adults with lower kidney function are at higher risk of worsening cognitive function.
© The Author 2014. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  aging; chronic kidney disease; cognitive function; congestive heart failure; myocardial infarction; prospective study; stroke; successful aging

Mesh:

Substances:

Year:  2014        PMID: 24844846      PMCID: PMC4070934          DOI: 10.1093/aje/kwu102

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  35 in total

1.  Using telephone and informant assessments to estimate missing Modified Mini-Mental State Exam scores and rates of cognitive decline. The cardiovascular health study.

Authors:  Alice M Arnold; Anne B Newman; Norma Dermond; Mary Haan; Annette Fitzpatrick
Journal:  Neuroepidemiology       Date:  2009-04-28       Impact factor: 3.282

2.  Accounting for bias due to selective attrition: the example of smoking and cognitive decline.

Authors:  Jennifer Weuve; Eric J Tchetgen Tchetgen; M Maria Glymour; Todd L Beck; Neelum T Aggarwal; Robert S Wilson; Denis A Evans; Carlos F Mendes de Leon
Journal:  Epidemiology       Date:  2012-01       Impact factor: 4.822

3.  Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study.

Authors:  Manjula Kurella; Glenn M Chertow; Linda F Fried; Steven R Cummings; Tamara Harris; Eleanor Simonsick; Suzanne Satterfield; Hilsa Ayonayon; Kristine Yaffe
Journal:  J Am Soc Nephrol       Date:  2005-05-11       Impact factor: 10.121

4.  Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study.

Authors:  L H Kuller; L Shemanski; T Manolio; M Haan; L Fried; N Bryan; G L Burke; R Tracy; R Bhadelia
Journal:  Stroke       Date:  1998-02       Impact factor: 7.914

5.  Estimating glomerular filtration rate from serum creatinine and cystatin C.

Authors:  Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey
Journal:  N Engl J Med       Date:  2012-07-05       Impact factor: 91.245

6.  Serum cystatin C and the risk of Alzheimer disease in elderly men.

Authors:  J Sundelöf; J Arnlöv; E Ingelsson; J Sundström; S Basu; B Zethelius; A Larsson; M C Irizarry; V Giedraitis; E Rönnemaa; M Degerman-Gunnarsson; B T Hyman; H Basun; L Kilander; L Lannfelt
Journal:  Neurology       Date:  2008-09-30       Impact factor: 9.910

7.  Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System.

Authors:  E J Erlandsen; E Randers; J H Kristensen
Journal:  Scand J Clin Lab Invest       Date:  1999-02       Impact factor: 1.713

8.  Kidney function is associated with the rate of cognitive decline in the elderly.

Authors:  Aron S Buchman; D Tanne; P A Boyle; R C Shah; S E Leurgans; D A Bennett
Journal:  Neurology       Date:  2009-08-05       Impact factor: 9.910

Review 9.  Cognitive function in chronic kidney disease.

Authors:  Magdalena Madero; Ambreen Gul; Mark J Sarnak
Journal:  Semin Dial       Date:  2008 Jan-Feb       Impact factor: 3.455

10.  Cystatin C and aging success.

Authors:  Mark J Sarnak; Ronit Katz; Linda F Fried; David Siscovick; Brian Kestenbaum; Stephen Seliger; Dena Rifkin; Russell Tracy; Anne B Newman; Michael G Shlipak
Journal:  Arch Intern Med       Date:  2008-01-28
View more
  20 in total

Review 1.  The assessment of cognitive function in older adult patients with chronic kidney disease: an integrative review.

Authors:  Mary Hannan; Alana Steffen; Lauretta Quinn; Eileen G Collins; Shane A Phillips; Ulf G Bronas
Journal:  J Nephrol       Date:  2018-05-25       Impact factor: 3.902

2.  The association of prediagnosis social support with survival after heart failure in the Cardiovascular Health Study.

Authors:  Paulina Kaiser; Norrina Allen; Joseph A C Delaney; Calvin H Hirsch; Mercedes Carnethon; Alice M Arnold; Michelle C Odden
Journal:  Ann Epidemiol       Date:  2020-01-09       Impact factor: 3.797

3.  Cystatin C, cognition, and brain MRI findings in 90+-year-olds.

Authors:  Wei Ling Lau; Mark Fisher; Dana Greenia; David Floriolli; Evan Fletcher; Baljeet Singh; Seyed Ahmad Sajjadi; Maria M Corrada; Christina Whittle; Claudia Kawas; Annlia Paganini-Hill
Journal:  Neurobiol Aging       Date:  2020-04-29       Impact factor: 4.673

4.  Kidney Function and Cerebral Blood Flow: The Rotterdam Study.

Authors:  Sanaz Sedaghat; Meike W Vernooij; Elizabeth Loehrer; Francesco U S Mattace-Raso; Albert Hofman; Aad van der Lugt; Oscar H Franco; Abbas Dehghan; M Arfan Ikram
Journal:  J Am Soc Nephrol       Date:  2015-08-06       Impact factor: 10.121

Review 5.  Dementia risk in renal dysfunction: A systematic review and meta-analysis of prospective studies.

Authors:  Kay Deckers; Ileana Camerino; Martin P J van Boxtel; Frans R J Verhey; Kate Irving; Carol Brayne; Miia Kivipelto; John M Starr; Kristine Yaffe; Peter W de Leeuw; Sebastian Köhler
Journal:  Neurology       Date:  2016-12-14       Impact factor: 9.910

6.  A Warning About Using Predicted Values From Regression Models for Epidemiologic Inquiry.

Authors:  Elizabeth L Ogburn; Kara E Rudolph; Rachel Morello-Frosch; Amber Khan; Joan A Casey
Journal:  Am J Epidemiol       Date:  2021-06-01       Impact factor: 4.897

7.  Balance and cognitive decline in older adults in the cardiovascular health study.

Authors:  Claire C Meunier; Ellen Smit; Annette L Fitzpatrick; Michelle C Odden
Journal:  Age Ageing       Date:  2021-06-28       Impact factor: 10.668

8.  Association of Urine Biomarkers of Kidney Tubule Injury and Dysfunction With Frailty Index and Cognitive Function in Persons With CKD in SPRINT.

Authors:  Lindsay M Miller; Dena Rifkin; Alexandra K Lee; Manjula Kurella Tamura; Nicholas M Pajewski; Daniel E Weiner; Tala Al-Rousan; Michael Shlipak; Joachim H Ix
Journal:  Am J Kidney Dis       Date:  2021-02-27       Impact factor: 11.072

9.  Markers of kidney function, genetic variation related to cognitive function, and cognitive performance in the UK Biobank.

Authors:  Erin L Richard; Linda K McEvoy; Ian J Deary; Gail Davies; Steven Y Cao; Eyal Oren; John E Alcaraz; Andrea Z LaCroix; Jan Bressler; Rany M Salem
Journal:  BMC Nephrol       Date:  2022-04-27       Impact factor: 2.585

10.  Kidney disease as a determinant of cognitive decline and dementia.

Authors:  Thorleif Etgen
Journal:  Alzheimers Res Ther       Date:  2015-03-17       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.